These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6742821)

  • 1. Pharmacokinetics of intranasally applied medication during a cold.
    Phillpotts RJ; Davies HW; Willman J; Tyrrell DA; Higgins PG
    Antiviral Res; 1984 Apr; 4(1-2):71-4. PubMed ID: 6742821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative intranasal pharmacokinetics of interferon using two spray systems.
    Davies HW; Scott GM; Robinson JA; Higgins PG; Wootton R; Tyrrell DA
    J Interferon Res; 1983; 3(4):443-9. PubMed ID: 6672115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
    Samo TC; Greenberg SB; Couch RB; Quarles J; Johnson PE; Hook S; Harmon MW
    J Infect Dis; 1983 Sep; 148(3):535-42. PubMed ID: 6619578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers.
    Higgins PG; Al-Nakib W; Willman J; Tyrrell DA
    J Interferon Res; 1986 Apr; 6(2):153-9. PubMed ID: 3014018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose.
    Samo TC; Greenberg SB; Palmer JM; Couch RB; Harmon MW; Johnson PE
    J Infect Dis; 1984 Aug; 150(2):181-8. PubMed ID: 6381611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM
    J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2.
    Phillpotts RJ; Scott GM; Higgins PG; Wallace J; Tyrrell DA; Gauci CL
    Antiviral Res; 1983 Aug; 3(2):121-36. PubMed ID: 6312877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit.
    Tyrrell DA
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B(Suppl B):153-6. PubMed ID: 3025154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans.
    Johnson PE; Greenberg SB; Harmon MW; Alford BR; Couch RB
    J Clin Microbiol; 1976 Jul; 4(1):106-7. PubMed ID: 182714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.
    Douglas RM; Albrecht JK; Miles HB; Moore BW; Read R; Worswick DA; Woodward AJ
    J Infect Dis; 1985 Apr; 151(4):731-6. PubMed ID: 2982972
    [No Abstract]   [Full Text] [Related]  

  • 14. Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.
    Herzog C; Berger R; Fernex M; Friesecke K; Havas L; Just M; Dubach UC
    Antiviral Res; 1986 May; 6(3):171-6. PubMed ID: 3524441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM; Gwaltney JM; Adams KF; Hayden FG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.
    Douglas RM; Moore BW; Miles HB; Davies LM; Graham NM; Ryan P; Worswick DA; Albrecht JK
    N Engl J Med; 1986 Jan; 314(2):65-70. PubMed ID: 3001518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of human fibroblast interferon to protect against rhinovirus infection.
    Scott GM; Reed S; Cartwright T; Tyrrell D
    Arch Virol; 1980; 65(2):135-9. PubMed ID: 6158933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses induced by intranasal imiquimod and implications for therapeutics in rhinovirus infections.
    Clejan S; Mandrea E; Pandrea IV; Dufour J; Japa S; Veazey RS
    J Cell Mol Med; 2005; 9(2):457-61. PubMed ID: 15963264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product characteristics and pharmacokinetics of intranasal ipratropium bromide.
    Wood CC; Fireman P; Grossman J; Wecker M; MacGregor T
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1111-6. PubMed ID: 7751527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.
    Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H
    J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.